EUVIMEDEUVIMED entdecken
Crossref

Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer

Sibel Goksel, Ugur Avci

Hormone and Metabolic Research · 01.10.2023 · 55 (10) · 677-683

DOI: 10.1055/a-2077-7246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2023. Verfasst von Sibel Goksel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, Recep Tayyip Erdoğan University, Rize, Turkey. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study was to evaluate the effect of radioactive iodine (RAI) treatment application time and clinical, histopathological factors on ablation success in patients with operated papillary thyroid cancer (PTC) in low and intermediate-risk. One hundred sixty-one patients with PTC in the low and intermediate-risk were evaluated. Most patients (89.4%) were in the low-risk, and 10.6% were in the intermediate-risk. When the patients were divided into two groups according to the date of receiving RAI treatment after surgery, those who received early treatment (≤3 months) constituted the majority of the patients (72.7%). Seventeen patients received 1.85 Gigabecquerel (GBq), 119 3.7 GBq, 25 5.55 GBq RAI. Most patients (82%) achieved ablation success after the first RAI treatment. The time interval between surgery and RAI treatment did not affect ablation success. Stimulated Tg level measured on the RAI treatment day was an independent predictive factor for successful ablation (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryHumansThyroid Cancer, PapillaryIodine RadioisotopesRetrospective StudiesThyroidectomy

Substanzen

Iodine-131Iodine Radioisotopes

Autor:innen und Institutionen

  • Nuclear Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
  • Nuclear Medicine, Adnan Menderes University, Aydın, Turkey.
  • Endocrinology, Recep Tayyip Erdoğan University, Rize, Turkey.

Zitieren

APA

Goksel, S., & Avci, U. (2023). Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer. Hormone and Metabolic Research, 55(10), 677-683. https://doi.org/10.1055/a-2077-7246

Vancouver

Goksel S, Avci U. Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer. Hormone and Metabolic Research. 2023;55(10):677-683. doi:10.1055/a-2077-7246

BibTeX
@article{Goksel2023,
  author = {Goksel, Sibel and Avci, Ugur},
  title = {Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer},
  journal = {Hormone and Metabolic Research},
  year = {2023},
  volume = {55},
  number = {10},
  pages = {677--683},
  doi = {10.1055/a-2077-7246}
}
Kostenlos starten →